Candida vaginitis. Candidiasis of vulva and vagina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 18 to 45 years old; being married; diagnosis of candidiasis; single sexual partner; no history of allergy to drugs and plants; being literate; giving consent to participate in the study. Exclusion criteria: having any known chronic disease; use of any antibiotics and corticosteroids in the past two weeks; receiving antifungal drugs in the past 4 weeks; currently taking oral contraceptives; existence of other vaginal infections; any sores or lumps at the cervix; experience of severe stress over the past month; known Pregnancy; lactation; currently use of other herbal medicines; participation at another trial.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to the treatment. Timepoint: 10-15 days after the initiation of intervention. Method of measurement: Assessment of vaginal pH, direct observation, secretion culture.;Relapse of the infection. Timepoint: 30-35 days after the initiation of intervention. Method of measurement: Assessment of vaginal pH, direct observation, secretion culture. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual function score. Timepoint: Before intervention, 30-35 days after the initation of therapy. Method of measurement: Female sexual function Index (FSFI).;Adverse events. Timepoint: 10-15 days after the initation of therapy. Method of measurement: Self-report.;Clinical complaints. Timepoint: Baseline, 10-15 and 30-35 days after initiation of intervention. Method of measurement: Self-report.;Client satisfaction. Timepoint: 10-15 and 30-35 days after the initation of intervention. Method of measurement: Self-report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Midwifery Department, Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences